These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37814829)

  • 1. β-Lactams plus doxycycline versus azithromycin for treatment of severe community-acquired pneumonia in critically ill patients.
    Greco Kinney A; Kovacic Scherrer N; Sarkar S; Jain P; Wen S; Hadique S
    J Antimicrob Chemother; 2023 Dec; 78(12):2816-2823. PubMed ID: 37814829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Empiric Antibiotic Treatment Regimens for Hospitalized, Non-severe Community-acquired Pneumonia: A Retrospective, Multicenter Cohort Study.
    Reeves SD; Hartmann AP; Tedder AC; Juang PA; Hofer M; Kollef MH; Micek ST; Betthauser KD
    Clin Ther; 2024 Apr; 46(4):338-344. PubMed ID: 38403509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin plus β-lactam versus levofloxacin plus β-lactam for severe community-acquired pneumonia: A retrospective nationwide database analysis.
    Suzuki J; Sasabuchi Y; Hatakeyama S; Matsui H; Sasahara T; Morisawa Y; Yamada T; Yasunaga H
    J Infect Chemother; 2019 Dec; 25(12):1012-1018. PubMed ID: 31227381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of β-Lactam Plus Macrolide Versus Fluoroquinolone on 30-Day Readmissions for Community-Acquired Pneumonia.
    Gilbert TT; Arfstrom RJ; Mihalovic SW; Dababneh AS; Varatharaj Palraj BR; Dierkhising RA; Mara KC; Lessard SR
    Am J Ther; 2020; 27(2):e177-e182. PubMed ID: 30418221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azithromycin combination therapy for community-acquired pneumonia: propensity score analysis.
    Ito A; Ishida T; Tachibana H; Tokumasu H; Yamazaki A; Washio Y
    Sci Rep; 2019 Dec; 9(1):18406. PubMed ID: 31804572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Macrolide Deescalation in Severe Community-acquired Pneumonia.
    Hopkins TM; Juang P; Weaver K; Kollef MH; Betthauser KD
    Clin Ther; 2019 Dec; 41(12):2540-2548. PubMed ID: 31676040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Efficacy of Beta-Lactams and Macrolides in the Treatment of Pediatric Pneumonia: A Systematic Review.
    Al Saeedy D; Gillani SW; Al-Salloum J; Moosvi A; Eissa M; Gulam SM
    Curr Pediatr Rev; 2020; 16(4):307-313. PubMed ID: 32895041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of Beta-Lactam plus Doxycycline for Patients Hospitalized with Community-Acquired Pneumonia.
    Uddin M; Mohammed T; Metersky M; Anzueto A; Alvarez CA; Mortensen EM
    Clin Infect Dis; 2022 Aug; 75(1):118-124. PubMed ID: 34751745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxycycline vs. macrolides in combination with a β-lactam antibiotic for the treatment of community-acquired pneumonia in inpatients.
    Aldhahri RK; Gabb SG; Shoaib OA; Almadani RM; Eljaaly K; Thabit AK
    Eur J Med Res; 2022 Dec; 27(1):279. PubMed ID: 36482485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: a US-based study.
    Frei CR; Jaso TC; Mortensen EM; Restrepo MI; Raut MK; Oramasionwu CU; Ruiz AD; Makos BR; Ruiz JL; Attridge RT; Mody SH; Fisher A; Schein JR
    Curr Med Res Opin; 2009 Apr; 25(4):859-68. PubMed ID: 19231913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of doxycycline on Clostridioides difficile infection in patients hospitalized with community-acquired pneumonia.
    O'Leary AL; Chan AK; Wattengel BA; Xu J; Mergenhagen KA
    Am J Infect Control; 2024 Mar; 52(3):280-283. PubMed ID: 37921728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of β-Lactam Monotherapy vs Macrolide Combination Therapy for Children Hospitalized With Pneumonia.
    Williams DJ; Edwards KM; Self WH; Zhu Y; Arnold SR; McCullers JA; Ampofo K; Pavia AT; Anderson EJ; Hicks LA; Bramley AM; Jain S; Grijalva CG
    JAMA Pediatr; 2017 Dec; 171(12):1184-1191. PubMed ID: 29084336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of azithromycin versus clarithromycin in combination with beta-lactams to treat community-acquired pneumonia in hospitalized patients: a systematic review.
    Al-Salloum J; Gillani SW; Mahmood RK; Gulam SM
    J Int Med Res; 2021 Oct; 49(10):3000605211049943. PubMed ID: 34719987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of β-lactam and macrolide combination therapy for treating community-acquired pneumonia patients hospitalized in the intensive care unit: Propensity score analysis of a prospective cohort study.
    Ito A; Ishida T; Tachibana H; Nakanishi Y; Tokioka F; Yamazaki A; Washio Y; Irie H; Otake T
    J Infect Chemother; 2021 Oct; 27(10):1447-1453. PubMed ID: 34147355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levofloxacin Versus Ceftriaxone and Azithromycin Combination in the Treatment of Community Acquired Pneumonia in Hospitalized Patients.
    Izadi M; Dadsetan B; Najafi Z; Jafari S; Mazaheri E; Dadras O; Heidari H; SeyedAlinaghi S; Voltarelli F
    Recent Pat Antiinfect Drug Discov; 2018; 13(3):228-239. PubMed ID: 30360748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Effectiveness of First-Line and Alternative Antibiotic Regimens in Hospitalized Patients With Nonsevere Community-Acquired Pneumonia: A Multicenter Retrospective Cohort Study.
    Bai AD; Srivastava S; Wong BKC; Digby GC; Razak F; Verma AA
    Chest; 2024 Jan; 165(1):68-78. PubMed ID: 37574164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe community-acquired pneumonia treated with β-lactam-respiratory quinolone vs. β-lactam-macrolide combination.
    Karhu J; Ala-Kokko TI; Ohtonen P; Syrjälä H
    Acta Anaesthesiol Scand; 2013 May; 57(5):587-93. PubMed ID: 23379766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of ceftriaxone plus doxycycline in the treatment of patients hospitalized with community-acquired pneumonia.
    Flanders SA; Dudas V; Kerr K; McCulloch CE; Gonzales R
    J Hosp Med; 2006 Jan; 1(1):7-12. PubMed ID: 17219465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between time to clinical response and outcomes among Pneumonia Outcomes Research Team (PORT) risk class III and IV hospitalized patients with community-acquired pneumonia who received ceftriaxone and azithromycin.
    Zasowski E; Butterfield JM; McNutt LA; Cohen J; Cosler L; Pai MP; Gottwald J; Chen WZ; Lodise TP
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3804-13. PubMed ID: 24752270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia.
    Teh B; Grayson ML; Johnson PD; Charles PG
    Clin Microbiol Infect; 2012 Apr; 18(4):E71-3. PubMed ID: 22284533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.